sc 51089 has been researched along with 5,8,11-eicosatriynoic acid in 1 studies
Studies (sc 51089) | Trials (sc 51089) | Recent Studies (post-2010) (sc 51089) | Studies (5,8,11-eicosatriynoic acid) | Trials (5,8,11-eicosatriynoic acid) | Recent Studies (post-2010) (5,8,11-eicosatriynoic acid) |
---|---|---|---|---|---|
41 | 1 | 19 | 27 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Craib, SJ; Ellington, HC; Pertwee, RG; Ross, RA | 1 |
1 other study(ies) available for sc 51089 and 5,8,11-eicosatriynoic acid
Article | Year |
---|---|
A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonic Acids; Bronchi; Calcium Channel Blockers; Capsaicin; Cyclohexanols; Dose-Response Relationship, Drug; Endocannabinoids; Fatty Acids, Unsaturated; Guinea Pigs; Hydrazines; In Vitro Techniques; Indomethacin; Lipoxygenase; Muscle Contraction; Oxazepines; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Drug; Rimonabant; Thiorphan | 2001 |